María Rosa Ulla - Concepedia

Author

María Rosa Ulla

Also Known As

Federico Perez Manghi, M R Ulla, M. R. Ulla, M. Ulla, M.R. Ulla, Maria Rosa Ulla, Maria Ulla, María R. Ulla, María Rosa Ulla, María Ulla

Publications

Citations

H-Index

Concepts

All Affiliations

University of Toronto Université Laval St. Michael's Hospital Semmelweis University Medical University of South Carolina

About

María Rosa Ulla is an author at University of Toronto specializing in medicine, metabolic syndrome, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	5.6K
2	Diabetes	3	3	5.1K
3	Public Health	2	2	2.8K
4	Health Sciences	1	1	12
5	Endocrinology	1	1	12

María Rosa Ulla

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyCardiovascular Outcomes	2019	2.8K
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed, The Lancet Diabetes ManagementCardiovascular DiseaseDiabetesClinical TrialsType 2	2018	1.7K
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementUrologyChronic Kidney DiseaseDiabetes	2019	600
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial Bente Langdahl, Cesar Libanati, Daria B. Crittenden, The Lancet Bone DiseaseSclerostinBone HealthOsteopathyGynecology	2017	450
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease Zien Zhou, Meg Jardine, Qiang Li, Stroke	2021	111
Genotypes and clinical aspects associated with bone mineral density in Argentine postmenopausal women Adriana Pérez, María Rosa Ulla, Beatriz A. García, Journal of Bone and Mineral Metabolism Bone DiseaseBone HealthArgentine Postmenopausal WomenBone Mineral DensityGynecology	2008	35
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial Tae Won Yi, Brendan Smyth, Gian Luca Di Tanna, American Journal of Kidney Diseases Metabolic SyndromeHypertensionUrologyRenal FunctionCardiovascular Disease	2023	25
Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis Ariel Sánchez, Lucas R. Brun, Helena Salerni, Journal of Osteoporosis	2016	15
Body Composition of Patients With Primary Hypothyroidism Evaluated by Dual-Energy X-ray Absorptiometry and Its Changes After Treatment With Levo-Thyroxine Ariel Sánchez, Hugo Carretto, María Rosa Ulla, The Endocrinologist Email AddressEndocrine DiseaseBody CompositionHealth Information ExchangeParathyroid Hormone	2004	12
Bone mineral content in cyclosporine-treated renal transplant patients. P. Massari, Gabriela Garay, María Rosa Ulla PubMed UrologyKidney TransplantBone Mineral ContentKidney TransplantationTransplantation Medicine	1994	11

Page 1